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Fatal multidrug-resistant Acinetobacter baumannii pneumonia in Maputo, 
Mozambique: a case report. 
 
Acinetobacter baumannii is one of the six most important multidrug-resistant 
(MDR) microorganisms isolated in hospitalised patients worldwide, having an 
extraordinary capacity to spread to different areas1.In the last three decades A. 
baumannii has acquired resistance to antibiotics including carbapenems and 
even polymyxins, representing a challenge for achieving effective antibacterial 
treatment1,2. In the global priority list of antibiotic-resistant bacteria of the World 
Health Organization, A. baumannii is considered the most critical pathogen3. 
Knowledge of the epidemiology and antibacterial susceptibility profile of A. 
baumannii is still incomplete in many parts of the world including Africa. Here, 
we report a fatal pulmonary infection by MDR A. baumannii in Maputo, 
Mozambique. 
 
In 2014, a woman in her 20’s, with HIV infection on antiretroviral treatment for 
the preceding 12 months, was admitted to the Maputo Central Hospital with 
cough, dyspnoea and seizures of acute presentation. Physical examination 
revealed: a Glasgow score of 15/15, temperature 38.2°C, blood pressure 
180/120mmHg, heart rate 100 bpm, and respiratory rate 24 rpm. Thick and thin 
smear tests for malaria were negative. Laboratory analyses during 
hospitalization showed anaemia (haematocrit 24.9% and haemoglobin 8.3g/dL), 
leukopenia (white blood cell count 2.9 x 109/L), elevated transaminases (AST 
157 IU and ALT 726IU), and kidney failure (maximum creatinine and urea levels 
were 363 µM/L and 29.4 µM/L respectively); the estimated glomerular filtration 
(Cockcroft-Gault Equation) was 18.8 mL/min. Chest X-ray was performed and 
only a cardiomegaly was reported. The nadir CD4 count was 192cells/mL. 
Sputum Gram stain and blood culture were not performed. The patient received 
penicillin, cotrimoxazole, and oxygen but died on day 14 of hospitalisation. Pre-
mortem clinical diagnoses were: HIV/AIDS, Kaposi’s sarcoma, dilated 
cardiomyopathy, kidney failure, and pulmonary hypertension. The patient was 
not intubated or in mechanical ventilation. 
The case was included in the CaDMIA project, a validation study of a minimally 
invasive autopsy (MIA) protocol against the complete diagnostic autopsy 
(CDA)4,5. A universal screening for several key pathogens was conducted, and 
microbiological analysis were performed according to the histopathological 
findings4,5. The autopsy revealed a severe pyogenic pneumonia (Figure1). 
Serum samples tested positive for antibodies against HIV with a viral load of 
182 copies/mL. Lung samples resulted negative for tuberculosis, Cryptococcus, 
Toxoplasma gondii, Pneumocystis jirovecii and respiratory viruses by PCR 
testing. A. baumannii was isolated from brain, lung and liver samples. Gram 
negative bacilli were visible in the Gram stain of histological lung samples 
(Fig1), brain, and liver. A. baumannii was also identified by 16S rRNA PCR in 
plasma, brain, lung, liver and cerebrospinal fluid samples. The cause of death 
was assigned to fatal pneumonia caused by a MDR A. baumannii infection, 
following a previously described algorithm 6. Clinical diagnosis of Kaposi’s 
sarcoma and dilated cardiomyopathy were not confirmed at autopsy. 
 
Antibiotic susceptibility tests were performed and interpreted according to the 
EUCAST guidelines (version 7.0,2017; http://www.eucast.org) which consider 
A. baumannii intrinsically resistant to penicillins and cephalosporins. In addition, 
the strain was resistant to the following antibiotics: ciprofloxacin, levofloxacin, 
trimethoprim-sulphamethoxazole, and gentamicin; showing intermediate 
resistance to meropenem (4 μg/ml) and susceptibility to amikacin, tobramycin, 
imipenem and colistin. The MIC of tigecycline was 1μg/ml. Multi-Locus 
Sequence Typing following the Pasteur scheme 
(https://pubmlst.org/abaumannii/) identified all the A. baumannii isolates as 
belonging to international clone II and sequence type 2(ST2).  
 
Few data are available in the literature regarding A. baumannii in Africa. A 
recent report analysed 65 strains from 5 different countries and found a high 
prevalence of MDR strains7. International clone II/ST2 isolates belong to one of 
the major clonal lineages associated with the spread of MDR A. baumannii 
worldwide, but in Africa they have only been reported in Algeria and Kenya8,9. 
Two recent studies10,11 (one of them conducted at the Maputo Central Hospital) 
reported non-MDR A. baumannii in Mozambique, whereas, to our knowledge, 
this is the first report of a MDR A. baumannii strain in this country. The patient 
had several known risk factors for acquiring A. baumannii infection such as 
severe immunosuppression and having been hospitalised for two weeks. 
However, the final cause of death was only identified after a complete 
diagnostic autopsy and in depth microbiological studies were carried out. 
Diagnostic autopsies are rarely performed in sub-Saharan Africa due to, among 
others, the lack of resources and trained pathologists. We show that a 
standardised minimally invasive sampling procedure can provide accurate 
identification of a pathogen causing death. This method may improve the 
capacity of the current surveillance methods to detect bacterial infections and 
associated antimicrobial resistance. Our report highlights the utility of post-
mortem investigations for accurate determination of cause of death and the 
need for microbiological surveillance to tackle the growing problem of 
nosocomial MDR infections in low-income countries. 
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Figure1. Fatal MDR A. baumannii infection: microbiological and pathological 
results of post-mortem samples. 
Histological images of relevant findings. (A.1) Lung with pyogenic pneumonia 
(hematoxylin and eosin, 100×); (A.2) Gram negative bacteria (A. baumannii) 
pneumonia (arrow) infecting the lung (gram stain, 1000×); (A.3) Heart with 
hypertrophy (hematoxylin and eosin, 100×) (A.4) Spleen with lymphocytic 
depletion and congestion (hematoxylin and eosin, 100×)  
